News

The Supreme Court upheld a key plank of Obamacare against a constitutional attack on Friday by a 6–3 vote. But in the process ...
The pending Supreme Court challenge to the Affordable Care Act's preventive services mandate has serious implications for the ...
Mobile units are being used to test for hepatitis C in one of the areas where the virus is thought to be particularly ...
Only half of the New Zealanders estimated to have hepatitis C know it, so more easy-to-access testing is part of the plan.ANDY JACKSON / Stuff It’s the number one reason Kiwis need a liver ...
Thousands of people in the UK will be screened for hepatitis C virus in a new pilot aimed at expanding use of antiviral therapies to eradicate the infectious – and eliminate it altogether by ...
Commentary Published: October 2000 Hepatitis C Virus and eliminating post-transfusion hepatitis Harvey J. Alter & Michael Houghton Nature Medicine 6, 1082–1086 (2000) Cite this article ...
Chronic hepatitis C is a growing health problem worldwide that has attracted increased attention in recent years. Treatment with peginterferon and ribavirin combination had previously been the ...
Competing hepatitis C combination drugs from AbbVie and Gilead are now approved in the EU, as the companies aim to treat patients who cannot be cured with established regimens. AbbVie’s Maviret ...
Future research directed toward identifying best screening methods and HBV risk tools will be necessary to reduce the risk of reactivation of HBV infection after chemotherapy. Purpose: Patients with ...
The new drug, Harvoni, released by pharmaceutical giant Gilead, promises a breakthrough in Hepatitis C treatment. It is orally administered, reduces the treatment span to 12 weeks, has fewer side ...